Clinical Trial Update: Creatine Treatment in Psychiatric Disorders [Phase 3]

View source ↗

Summary

This Phase 3 clinical trial update reports the completion of a study evaluating creatine as a treatment for schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Creatine (creatine)

Snippet

Sponsor: Beersheva Mental Health Center | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED